Rethinking the use of voriconazole therapeutic drug monitoring in allogeneic hematopoietic stem cell transplant recipients.
Brown
J
J
Freeman
B B
BB
D000935:Antifungal Agents / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001228:Aspergillosis / Q000517:prevention & control; D016903:Drug Monitoring; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells; D006801:Humans; D008297:Male; D011743:Pyrimidines / Q000008:administration & dosage / Q000493:pharmacokinetics*; D014184:Transplantation, Homologous; D014230:Triazoles / Q000008:administration & dosage / Q000493:pharmacokinetics*; D065819:Voriconazole
D000935:Antifungal Agents; D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole